Home Uncategorized UPMC creates AI-powered analytics company focused on chronic disease patients

UPMC creates AI-powered analytics company focused on chronic disease patients


Pittsburgh based UPMC launched a new artificial intelligence company It aims to help physicians identify patients with chronic diseases and connect them with treatment options.

understand intelligenceThe new company, incubated and funded by UPMC Enterprises, provides a clinical intelligence platform that “reads” detailed clinical notes into patients’ EMRs, said Aaron Browser, president and CEO, in an email. . Browser is also a co-founder of the Pittsburgh-based company along with Dr. Gillan El Saadawi, who serves as Realize’s CMO.

He explained that the platform leverages clinical models with artificial intelligence and natural language processing technology to collect information from complete patient charts including descriptive clinical notes.

These notes provide invaluable information about a patient in addition to the structured data found in EMR and data warehouses. But to access this information and understand the progress of the patient’s condition, these notes must be read and interpreted by a trained physician, he said.

“This rich patient story has effectively been implicated, resulting in wasted billions of dollars in intangible costs,” Bruiser said.

Realize Intelligence’s solution is able to analyze clinical notes with structured patient data in EMR and classify patients into specific disease populations. The platform can then help physicians pair patients with the treatments most likely to benefit them.

“Realize’s ability to assess massive amounts of unstructured data has added new dimension and depth to the analyzes we conduct, making them even more useful to our physicians as they relate to the communities we serve. life-changing medicine,” Dr. Oscar C. Marroquin, UPMC’s chief health care data and analysis officer, in a news release.

For example, the Realyze platform can identify patients who have been diagnosed with stage 3b chronic kidney disease and are not yet on dialysis, Bruiser said.

“These patients may be prioritized for referral to a specialist to provide better treatment and reduce the risk of having an ‘accident’ dialysis event,” he said.

Similarly, the platform can identify a cancer patient who matches the criteria for a new treatment and inform the clinician before presenting treatment options to the patient.

Looking ahead, Realize Intelligence aims to expand its customer base across health systems and health plans across the country and continue to develop packaged offerings to tackle chronic conditions and cancer, Bruiser said.

Photo: ipopba, Getty Images



Please enter your comment!
Please enter your name here